5 Results for "

PF-04971729

" in MedChemExpress (MCE) Product Catalog:
Products (5)

5 Results for "PF-04971729" in MCE Product Catalog:

5
5 Cited Publications
Cat. No.: HY-15461
CAS No.: 1210344-57-2
Purity:  99.92%
Synonyms: PF-04971729
Target:  

SGLT

Research Areas:  

Metabolic Disease

Ertugliflozin (PF-04971729) is a potent, selective and orally active inhibitor of the sodium-dependent glucose cotransporter 2 (SGLT2), with an IC50 of 0.877 nM for h-SGLT2 . Has the potential for the treatment of type 2 diabetes mellitus .
loading...
    loading...
5
5 Cited Publications
Cat. No.: HY-15461A
CAS No.: 1210344-83-4
Purity:  99.84%
Synonyms: PF-04971729 L-pyroglutamic acid
Target:  

SGLT

Research Areas:  

Metabolic Disease

Ertugliflozin L-pyroglutamic acid (PF-04971729 L-pyroglutamic acid) is a potent, selective and orally active inhibitor of the sodium-dependent glucose cotransporter 2 (SGLT2), with an IC50 of 0.877 nM for h-SGLT2 . Has the potential for the treatment of type 2 diabetes mellitus .
loading...
    loading...
Cat. No.: HY-15461R
CAS No.: 1210344-57-2
Synonyms: PF-04971729 (Standard)
Research Areas:  

Metabolic Disease

Ertugliflozin (Standard) is the analytical standard of Ertugliflozin. This product is intended for research and analytical applications. Ertugliflozin (PF-04971729) is a potent, selective and orally active inhibitor of the sodium-dependent glucose cotransporter 2 (SGLT2), with an IC50 of 0.877 nM for h-SGLT2 . Has the potential for the treatment of type 2 diabetes mellitus .
loading...
    loading...
Cat. No.: HY-15461S
CAS No.: 1298086-22-2
Synonyms: PF-04971729-d5
Ertugliflozin-d5 is the deuterium labeled Ertugliflozin . Ertugliflozin (PF-04971729) is a potent, selective and orally active inhibitor of the sodium-dependent glucose cotransporter 2 (SGLT2), with an IC50 of 0.877 nM for h-SGLT2 . Has the potential for the treatment of type 2 diabetes mellitus .
loading...
    loading...
Cat. No.: HY-15461S1
Synonyms: PF-04971729-d9
Ertugliflozin-d9 is deuterated labeled Ertugliflozin (HY-15461). Ertugliflozin (PF-04971729) is a potent, selective and orally active inhibitor of the sodium-dependent glucose cotransporter 2 (SGLT2), with an IC50 of 0.877 nM for h-SGLT2 . Has the potential for the treatment of type 2 diabetes mellitus .
loading...
    loading...